STLoke
05-04

$Eli Lilly(LLY)$  $Novo-Nordisk A/S(NVO)$  

Both overrated. I don't expect any more up side

Can LLY & NVO Continue to Thrive After Earnings?
LLY and NVO will release their financial reports this Tuesday and Thursday. Both of these weight-loss drug companies have risen by over 20% since the beginning of the year. ---------------------- Is weight-loss drug, like AI, a main investment theme this year? Would you buy weight-loss drug companies? Can Eil Lilly return to $800?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment